Saturday, July 13, 2013

Appeal from Remand of Nineteen-Plaintiff Products Case Dismissed

Nineteen plaintiff families filed a single complaint against Pfizer and other pharmaceutical companies in state court in West Virginia, alleging that Zoloft caused birth defects to children born of women ingesting it.  Only one of the plaintiff families was nondiverse from the defendants.  A West Virginia state rule required each family to be docketed separately and to pay a separate filing fee, but did not required them to fiile separate complaints. 

The pharmaceutical companies removed eighteen of the nineteen families to federal court, alleging diversity jurisdiction.  The district court remanded, holding that the action was really one civil action lacking complete diversity, and that the one nondiverse family was not fraudulently joined.

The Fourth Circuit held that the remand order was within the scope of 28 U.S.C. 1447(c) because it was based on the district court's lack of subject matter jurisdiction.  Therefore, the remand order was not reviewable on appeal under 28 U.S.C. 1447(d).

Retired Justice Sandra Day O'Connor, sitting by designation, joined the opinion.  E.D. v. Pfizer, No. 12-2188 (4th Cir. July 12, 2013).

PM 

http://lawprofessors.typepad.com/civpro/2013/07/appeal-from-remand-of-nineteen-plaintiff-products-case-dismissed.html

Mass Torts, Recent Decisions, Subject Matter Jurisdiction | Permalink

Comments

Post a comment